
TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Hair transplantation is a multi-billion dollar market with steady growth that shows no sign of slowing. Hair loss impacts over 50 million men worldwide and over two-thirds of men will experience some form of thinning or baldness before the age of 35. To meet the need of a growing number of men seeking hair restoration, technology has advanced by leaps and bounds to deliver pleasing, natural-looking results. ARTAS®, a robotic hair transplant system enhanced with Artificial Intelligence, is Venus Concept’s state-of-the-art answer to hair restoration, gives clinicians the edge in providing an attractive hair loss solution to growing consumer demand. To highlight why ARTAS® is the best option for clinics looking to tap into this lucrative market, we recently followed the patient journey of our contest winner Nico, who won the opportunity to have a hair restoration procedure performed by Dr. Gregory Turowski MD, Ph.D., FACS.
Dr. Turowsky was impressed with the ARTAS® hair transplantation technology from the beginning. An early adopter of the technology, his device quickly rose to the top of the charts, becoming fourth in the world for the number of procedures performed. He notes the precision, the repetitiveness, and the quality of the system, thanks to the Artificial Intelligence enhancing the equipment. The speed of the machine, he notes, is also something to take into consideration. On Nico, ARTAS® was able to perform almost 2000 grafts per hour, meaning an entire procedure can be completed in a day, rather than over several days, maximizing the number of patients Dr. Turowsky’s clinic is able to treat. His patients, including Nico, appreciate that with ARTAS® they have minimal pain, minimal scarring, and minimal downtime, with natural-looking results.
The ARTAS® hair restoration device replaces the old method of manual Follicular Unit Extraction (FUE) with robotic FUE. Using advanced image-guided robotics, ARTAS® precisely analyzes and dissects the best grafts from the patient’s donor area thousands of times per session, and then accurately identifies where they should be implanted to achieve a seamless,
natural-looking hairline that’s customized to each patient. Using an integrated Artificial Intelligence software, ARTAS® enables accurate and efficient harvesting, recipient site-making, and implantation functionality in one device, using image-guided robotics for precise and repeatable follicular unit dissection.
With ARTAS®, you’re acquiring not only the cutting-edge hair restoration capabilities of the device—you’re also getting the benefit of Venus Concept’s robust support.
First and foremost, ARTAS® was designed with patients in mind; however, the device is also optimized to make the transplantation process easier for providers. Robotic hair procedures are quicker, reducing the time and in-clinic costs associated with manual FUE hair restoration. In addition, ARTAS® is equipped with a robotic arm that uses pneumatic pressure to extract and reinsert the follicles, eliminating what can be a physically strenuous session for practicians.
We’re also invested in building awareness and patient demand for the procedure. Because we’re continually positioning our devices as the best in the industry via our vast web presence, promotions, and social media, ARTAS® comes with built-in brand recognition. Your clinic can leverage that recognition to its own benefit by offering clients technology that they already know, respect, and trust.
In particular, we focus special attention on educating and informing people who may feel reluctant to take the major step of getting surgery for their hair loss. To this day, many clients are still concerned about the stigma of baldness and undergoing hair restoration treatments. By augmenting the experience with robotics and a futuristic AI program, and through initiatives like our patient contest, we’re transforming the public image of hair restoration to one that’s positive and exciting.
All of our cutting-edge medical aesthetic devices are backed by Venus Concept’s scientific research and thorough clinical trials. We stand by them, and we want your clinic to succeed as much as you do. We’re here to support your practice through our practice enhancement program, our easy-entry subscription plans, and a wealth of expertise in marketing and growing aesthetic businesses. First and foremost, our competitive pricing model excludes hidden fees or pay-per-use gimmicks, allowing you to get the best return on your investment—and to pass those savings onto your clients.
Last year, a record-breaking number of ARTAS® hair restoration procedures were performed, proving that there’s never been a better time to offer hair restoration at your clinic.
To speak to an expert today about the future of hair restoration and what ARTAS® can do for your clinic, contact us using the button below.
For more information call: (888) 907-0115 // info@venusconcept.com // 235 Yorkland Blvd., Suite 900, Toronto, ON, M2J 4Y8 Canada
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA and licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite, and licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction. Venus Bliss™ has CE Mark as a non-invasive medical aesthetic device enabling a comprehensive approach leading to body contouring, addressing fat reduction, skin tightening, circumference reduction, and cellulite reduction.
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Velocity™ is cleared by the FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Fiore™ received regulatory approval in Israel for aesthetic and functional treatment of the vagina, labia and mons pubis. Venus Fiore™ is available for sale in India, Hong Kong, and other selected Asian countries.
The Venus Viva™ MD is cleared by the FDA, licensed by Health Canada and has CE Mark for the use in dermatological procedures requiring ablation and resurfacing of the skin using the Viva™/Viva™ MD applicator, and the non-invasive treatment, reduction in the appearance of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Epileve™ is cleared by FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types. Venus Epileve™ is also CE-Marked for hirsutism.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of cellulite on the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction. In the U.S., Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. These indications enable the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Skin™ is a skin care line of various lotions and creams intended to improve different aspects of skin appearance, skin serums, and skin nourishment solutions.
Copyright 2023 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More